The Madrid public health system has established itself as a leading player in the field of clinical research in Spain, according to data released today. During the closing ceremony of the Center for Biomedical Studies' scholarship awards at Rey Juan Carlos Public University, the Deputy Health Minister, Laura Gutiérrez, stressed that Madrid participated in 80% of the clinical research conducted in the country in 2024.
The event, held at the Manuel Becerra headquarters in the capital, brought together more than 70 professionals from 15 countries who received scholarships to pursue the Master’s in Molecular Oncology. This program, designed to promote training in a crucial field such as oncology, seeks to broaden the knowledge and skills of the participants in the fight against cancer.
Gutiérrez highlighted the relevance of Madrid's healthcare system in research, stating that "Madrid has become a national and international reference in the biosanitary field." The deputy minister emphasized the importance of continuing to support training and research that improve public health and the quality of life of citizens.
The awarding of scholarships represents a significant step toward strengthening research in oncology, a field that requires constant innovation to address the challenges posed by cancer. The diversity of nationalities among the scholars also reflects the region's commitment to attracting international talent and fostering global collaborations in the field of health.
This achievement, according to the vice-councillor, not only reinforces the prestige of Madrid's healthcare system, but also highlights the region's ability to lead large-scale projects that contribute to scientific advancement and the well-being of the entire population.
